Ying Meng Selected Research

Losartan (Cozaar)

6/2008	[Perindopril and losartan attenuate bleomycin A5-induced pulmonary fibrosis in rats].
2/2005	[Effects of angiotensin II and aldosterone on NF-kappaB binding activity in hepatic stellate cells].
7/2003	[Effect of ACE-I and AT-1 receptor blocker on the progression of CCl(4)-inducing rat hepatic fibrogenesis].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Meng Research Topics

Disease

46	Neoplasms (Cancer) 02/2024 - 05/2005
26	Fibrosis (Cirrhosis) 01/2024 - 07/2003
12	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 06/2008
10	Inflammation (Inflammations) 05/2024 - 04/2014
10	Infections 02/2024 - 01/2009
7	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2010
7	Lung Injury 01/2023 - 06/2004
6	Insulin Resistance 01/2023 - 09/2004
6	Mental Disorders (Mental Disorder) 01/2022 - 01/2019
6	Breast Neoplasms (Breast Cancer) 10/2021 - 11/2011
5	Brain Neoplasms (Brain Tumor) 04/2024 - 10/2015
5	Wounds and Injuries (Trauma) 02/2024 - 01/2014
5	Sepsis (Septicemia) 11/2023 - 01/2019
5	Pneumonia (Pneumonitis) 01/2023 - 01/2021
5	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2021
5	Obesity 01/2022 - 09/2004
5	Ovarian Neoplasms (Ovarian Cancer) 08/2018 - 05/2015
4	Stroke (Strokes) 01/2023 - 01/2018
4	Acute Lung Injury 01/2023 - 06/2004
4	Stomach Neoplasms (Stomach Cancer) 01/2021 - 11/2011
3	Meningioma (Meningiomas) 01/2024 - 10/2015
3	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 01/2017
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 01/2018
3	Ischemic Stroke 07/2022 - 09/2011
3	Hepatocellular Carcinoma (Hepatoma) 06/2021 - 01/2019
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 12/2020 - 02/2019
3	Glioma (Gliomas) 01/2019 - 08/2015
3	Emphysema 05/2015 - 06/2004
3	Chronic Obstructive Pulmonary Disease (COPD) 09/2013 - 06/2004
2	Lung Neoplasms (Lung Cancer) 05/2024 - 02/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 01/2023
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2024 - 12/2019
2	Colitis 11/2023 - 01/2022
2	Hyperglycemia 01/2023 - 01/2014

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 05/2024 - 07/2003
14	Biomarkers (Surrogate Marker)IBA 05/2024 - 11/2013
10	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2013
8	Angiotensin IIIBA 09/2021 - 01/2004
7	LipopolysaccharidesIBA 11/2023 - 09/2013
7	Bleomycin (Blenoxane)FDA LinkGeneric 09/2021 - 06/2008
6	Therapeutic UsesIBA 05/2024 - 06/2004
6	Anti-Bacterial Agents (Antibiotics)IBA 02/2024 - 01/2009
6	Messenger RNA (mRNA)IBA 01/2023 - 07/2003
5	InflammasomesIBA 11/2023 - 10/2017
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2015
5	Long Noncoding RNAIBA 01/2022 - 01/2018
5	Type 1 Angiotensin ReceptorIBA 09/2021 - 07/2003
5	CarbonIBA 02/2019 - 04/2015
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2010 - 07/2003
5	Perindopril FDA LinkGeneric 06/2008 - 07/2003
4	AntioxidantsIBA 05/2024 - 01/2015
4	Glutamine (L-Glutamine)FDA Link 12/2023 - 01/2019
4	Triglycerides (Triacylglycerol)IBA 02/2023 - 04/2020
4	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2022
4	EnzymesIBA 11/2022 - 04/2014
4	Coloring Agents (Dyes)IBA 02/2021 - 03/2006
4	Blood Glucose (Blood Sugar)IBA 10/2020 - 09/2004
4	AngiotensinsIBA 01/2018 - 07/2003
4	angiotensin I (1-7)IBA 01/2018 - 04/2014
4	AldosteroneIBA 10/2017 - 01/2007
4	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2008 - 07/2003
3	Testosterone (Sustanon)FDA Link 04/2024 - 11/2013
3	Interleukin-10 (Interleukin 10)IBA 11/2023 - 03/2003
3	CreatinineIBA 02/2023 - 10/2020
3	AlbuminsIBA 02/2023 - 01/2009
3	alamandineIBA 01/2023 - 01/2020
3	SmokeIBA 01/2021 - 06/2004
3	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 08/2018 - 05/2015
3	UbiquitinIBA 08/2018 - 05/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2018 - 04/2015
3	hydroxide ionIBA 01/2018 - 01/2017
3	Vitamin D FDA LinkGeneric 01/2018 - 01/2017
3	Angiotensin-Converting Enzyme 2IBA 10/2017 - 04/2014
3	Peptides (Polypeptides)IBA 08/2017 - 01/2012
3	Hematoxylin (Haematoxylon)IBA 05/2015 - 03/2006
3	Eosine Yellowish-(YS) (Eosin)IBA 05/2015 - 03/2006
3	Hydroxyproline (4 Hydroxyproline)IBA 05/2013 - 06/2008
3	Losartan (Cozaar)FDA LinkGeneric 06/2008 - 07/2003
3	NF-kappa B (NF-kB)IBA 06/2008 - 02/2005
3	Becaplermin (PDGF-BB)FDA Link 08/2005 - 07/2003
2	Volatile Fatty AcidsIBA 05/2024 - 11/2023
2	Estrone FDA Link 04/2024 - 01/2023
2	Gonadal Steroid Hormones (Sex Hormones)IBA 04/2024 - 01/2023
2	Retinaldehyde (Retinal)IBA 01/2024 - 01/2018
2	Immune Checkpoint ProteinsIBA 12/2023 - 01/2023
2	Peroxidase (Myeloperoxidase)IBA 11/2023 - 01/2015
2	QuercetinIBA 11/2023 - 01/2022
2	Interleukin-6 (Interleukin 6)IBA 11/2023 - 06/2009
2	GTP-Binding Proteins (G-Protein)IBA 01/2023 - 01/2020
2	HydrogenIBA 01/2023 - 01/2023
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2008
2	salicylhydroxamic acid (SHAM)IBA 01/2023 - 02/2012

Therapy/Procedure

32	Therapeutics 04/2024 - 06/2006
11	Deep Brain Stimulation 01/2023 - 01/2019
5	Drug Therapy (Chemotherapy) 12/2023 - 12/2015
4	Aftercare (After-Treatment) 01/2024 - 01/2020
3	Transcranial Magnetic Stimulation 10/2020 - 02/2019
2	Analgesia 02/2024 - 12/2019
2	Immunotherapy 01/2024 - 12/2023
2	Ligation 01/2023 - 01/2012